P234: Changing natural history in IBD – steroid-free remission and surgery in two cohorts (≤2009 and > 2009) – an interplay between disease pattern, biologics and adherenceECCO '18 Vienna
2018
P235: Does pregnancy adversely impact the health-related quality of life among women with IBD?ECCO '18 Vienna
2018
P237: Value of 75SeHCAT in the diagnosis of bile acid malabsorption in Crohn’s Disease with chronic diarrhoeaECCO '18 Vienna
2018
P238: A pilot study on the prevalence of obstructed defaecation syndrome among female patients of an inflammatory bowel disease cohortECCO '18 Vienna
2018
P239: The accuracy of intestinal ultrasound as compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileo-colonoscopyECCO '18 Vienna
2018
P240: Microscopic colitis is the most frequent diagnosis of patients with watery chronic diarrhoea and macroscopically normal colonoscopy in a context of clinical practiceECCO '18 Vienna
2018
P242: The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s diseaseECCO '18 Vienna
2018
P243: Colectomy rates in ulcerative colitis are low and decreasing: Ten-year follow-up data from the Swiss IBD cohort studyECCO '18 Vienna
2018
P244: Faecal calprotectin is a very reliable tool to predict and monitor the risk of relapse after therapeutic de-escalation in patients with inflammatory bowel diseasesECCO '18 Vienna
2018
P245: Development and validation of a Simplified Magnetic Resonance Index of Activity (sMaARIA) for Crohn’s diseaseECCO '18 Vienna
2018
P246: The association of serum 7α-hydroxy-4-cholesten-3-one (7C4) with Bile Acid Diarrhoea in patients with inflammatory bowel diseaseECCO '18 Vienna
2018
P247: MR enterography in Crohn’s disease: Comparison between diffusion-weighted imaging and intravenous contrast material in detection of active diseaseECCO '18 Vienna
2018
P248: IL-33/ST2 levels can predict mucosal response to anti-TNF therapy in ulcerative colitisECCO '18 Vienna
2018
P249: Endoscopic score vs. faecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healingECCO '18 Vienna
2018
P250: Serious infection in patients with Crohn’s disease newly treated with anti-integrin and anti-tumour necrosis factor agents: A real-world studyECCO '18 Vienna
2018